Skip to main content

Table 1 Demographics and baseline laboratory tests by treatment group.

From: Effects of 1,25-Dihydroxycholecalciferol on Recovery and Resolution of Late Transient Neonatal Hypocalcemia

(Units)

BirthWeight(kg)

Age (days)

Gender (M/F)

Ethnicity(Hispanic/Caucasian)

Ionized Calcium (mmol/L)

Phosphorus (mg/dL)

Mg (mg/dl)

Intact PTH (pg/mL)

25(OH) Vitamin D (ng/mL)

1,25(OH)2Vitamin D (pg/mL)

Placebo

4.06 ± 0.30

5.4 ± 0.5

6/1

6/1

0.86 ± 0.04

10.5 ± 0.3*

1.3 ± 0.1

26.0 ± 4.0

14.2 ± 2.8

159.4 ± 31.1

1,25(OH2)Vitamin D

3.73 ± 0.21

6.3 ± 0.4

6/1

4/3

0.88 ± 0.02

9.4 ± 0.2

1.2 ± 0.1

31.6 ± 4.7

15.1 ± 2.8

140.3 ± 10.7

Mean

3.91 ± 0.16

5.9 ± 0.3

  

0.87 ± 0.02

10.0 ± 0.2

1.2 ± 0.1

30.0 ± 3.0

15.0 ± 2.0

148.0 ± 14.0

Mother

   

HgA1C (%) 5.2 ± 0.4

Total Calcium(mg/dl) 9.35 ± 0.35

3.6 ± 0.2

3.0 ± 0.8

65.2 ± 16.3

15.3 ± 4.0

36.8 ± 5.0

  1. ; -test when compared to 1,25(OH)2 Vitamin D group Conversion factors:
  2. Phosphorus mmol/L = mg/dL 0.32.
  3. Magnesium mmol/L = mg/dL 0.5.